Industry News
Newly Launched AI-Powered Platform for OCT Scan Analysis is Transforming Eye Care
Altris AI, a pioneering Artificial Intelligence-powered platform for OCT scan analysis, has emerged as a game-changer in the eye care industry. Developed by Maria Znamenska, Ph.D. in Ophthalmology and owner of an ophthalmic clinic in Kyiv, Ukraine, Altris AI is a powerful decision-making support tool that detects over 100 retina pathologies on OCT scans.
With its comprehensive and accurate analysis capabilities, Altris AI has become a go-to platform for thousands of ophthalmologists and optometrists worldwide. It has also been adopted by numerous eye clinics and optometry centers as an essential business software.
The platform’s unique ability to differentiate between pathological and non-pathological OCT scans within a minute, detect minor, early, and rare pathologies, and provide a second opinion for complex OCT scans is unmatched in the industry. Using Altris AI, eye care businesses can reduce OCT examination time, increase revenue, and maintain consistent quality across their operations.
Altris AI comprises of three main modules: Severity Detection, Pathology Detection, and OCT Reports. The Severity Detection module enables users to differentiate between three severity levels, while the Pathology Detection module detects 49 pathologies and 54 pathological signs on OCT scans. The OCT Reports module provides comprehensive OCT reports for easy download.
With its commitment to data security, Altris AI is fully GDPR compliant and encrypts all data to prevent third-party access. The platform works with any OCT equipment, is vendor-neutral, and works with all data formats, including DICOM, jpg, and png, making the ophthalmic image management system more secure and efficient.
"At Altris AI, our mission is to set higher diagnostic standards in the eye care industry, resulting in better patient outcomes," said Dr. Maria Znamenska. "We are proud to offer a platform that is revolutionizing the way eye care professionals approach OCT scans."
Altris AI offers a free trial of its platform, available on the company website. The platform has a CE certificate, and the FDA clearance process is underway.
